m+Medelevator.RU
← Поиск публикаций
Small (Weinheim an der Bergstrasse, Germany) · 2026

Sequential Optimization of Multivariate Metal-Organic Framework Based Biocatalysis.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Liang Weibin, Zheng Sisi, Shalliker Ross Andrew, Doonan Christian, Li Feng

Аннотация

Efficient biocascades require integrated optimization of both biocatalysts and reaction conditions. In the present study, we employ a Latin hypercube sampling-coupled Bayesian optimization (LHS-BO) workflow to sequentially optimizes multivariate Zr-based E-MOF (E-MOF = enzyme@metal-organic framework biocomposite) design and the downstream glucose oxidase-horseradish peroxidase (GOx-HRP) biocascade. Enzymatic assays, attenuated total reflectance Fourier transform infrared spectroscopic (ATR-FTIR) and ultraviolet-visible (UV-Vis) spectroscopic analyses confirm that the optimized multivariate E-MOFs, ZG67, and ZH16, stabilize GOx and HRP in bioactive conformations. ZG67 and ZH16 achieve high encapsulation efficiency (92.2% ± 0.7% and 90.2% ± 1.3%), retained activity (87.1% ± 2.2% and 102.9% ± 14.9%), and enhanced stability under thermal (51.3% ± 1.4% and 45.9% ± 8.7%) and solvent treatments (>80% and ≈60% residual activity, respectively, in ethanol or acetonitrile). The optimal GOx-HRP cascade condition identified by LHS-BO (R49) achieves over 95% of the theoretical maximum 2,3-diaminophenazine (DAP) production rate predicted by the microkinetic model. The strong agreement amongst the experimental data, machine learning modeling, and kinetic modeling validates the robustness of this sequential E-MOF optimization framework. This generalized LHS-BO strategy provides a powerful tool for rational E-MOF and multi-enzyme cascade design, advancing biocatalysis and reaction engineering.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты